Exclusive Online Content

PAREXEL Advances Patient-Centric Drug Development With Introduction of its Patient Innovation Center

PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas of biopharmaceutical development including clinical trial design, recruitment, execution and market access. 

EXCLUSIVE ONLINE CONTENT

MARKET NEWS & TRENDS